![Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/10/1361/F1.large.jpg)
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases
![Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration](https://pub.mdpi-res.com/vaccines/vaccines-11-00278/article_deploy/html/images/vaccines-11-00278-g001.png?1676516145)
Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
![Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/2eca5c26-b3eb-48e8-bd6e-8d7222fefd9b/gr1.jpg)
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
![Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41421-022-00375-5/MediaObjects/41421_2022_375_Fig1_HTML.png)
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery
![Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379122002154-fx1.jpg)
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
![Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe](https://www.thelancet.com/cms/asset/18f48ea1-5898-49ea-9426-efaeeacd7d30/gr1.jpg)
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
![The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/09/05/2021.08.26.21262426/F1.large.jpg)
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
![Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron](https://content.presspage.com/uploads/2170/1920_51484223894-e94e0682d5-k.jpg?10000)
Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron
![A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio](https://journals.asm.org/cms/10.1128/mbio.01423-22/asset/d0ebc3f6-5a9d-478a-89ab-17be19c2b1fd/assets/images/medium/mbio.01423-22-f002.gif)
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio
![Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What](https://www.mdpi.com/vaccines/vaccines-10-01924/article_deploy/html/images/vaccines-10-01924-g002.png)
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
![Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c4700354-ace4-4afe-8822-4f3114ecf3a9/imcb12415-fig-0001-m.jpg)
Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library
![SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/f73b9dfc-2569-425e-ba38-99d908b3843b/gr1.jpg)